— Know what they know.
Not Investment Advice

IME.AX ASX

ImExHS Limited
1W: +16.1% 1M: -7.1% 3M: -7.1% YTD: -27.8% 1Y: +44.4% 3Y: -48.8% 5Y: -77.4%
A$0.33 ($0.23)
+0.00 (+0.00%)
 
ASX · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 48 · A$17.7M mcap · 52M float · 0.014% daily turnover

Balance Sheet Trends

Total Assets
$24M +8.8% ▲
5Y CAGR: +2.7%
Total Liabilities
$8M +7.2% ▲
5Y CAGR: +8.3%
Shareholders Equity
$16M +9.6% ▲
5Y CAGR: +0.4%
Cash & Investments
$3M +59.2% ▲
5Y CAGR: -21.1%
Total Debt
$566K -52.4% ▼
5Y CAGR: -19.7%
Net Debt
-$3M -209.5% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$4M$2M$2M$2M$3M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$4M$2M$2M$2M$3M
Net Receivables$6M$6M$5M$6M$9M
Inventory$84K$97K$112K$328K$146K
Other Current Assets$0$348K$844K$482K$0
Total Current Assets$11M$9M$9M$9M$13M
Property, Plant & Equip.$4M$4M$5M$3M$3M
Goodwill & Intangibles$14M$13M$9M$8M$7M
Long-Term Investments$1M$628K$512K$1M$521K
Other Non-Current Assets-$13M-$12M$0$0$0
Total Non-Current Assets$14M$12M$14M$13M$10M
Total Assets$25M$21M$23M$22M$24M
— Liabilities —
Accounts Payable$2M$2M$2M$3M$4M
Short-Term Debt$1M$545K$1M$794K$552K
Deferred Revenue$33K$14K$0$576K$1M
Other Current Liabilities$867K$2M$807K$389K$383K
Total Current Liabilities$6M$4M$6M$7M$8M
Long-Term Debt$1M$543K$216K$365K$14K
Other Non-Current Liab.$580K$0$0$0$0
Total Non-Current Liabilities$2M$608K$297K$444K$99K
Total Liabilities$8M$5M$7M$7M$8M
— Equity —
Common Stock$35M$38M$39M$40M$43M
Retained Earnings-$20M-$23M-$27M-$30M-$33M
Accumulated OCI$2M$676K$5M$5M$6M
Total Stockholders Equity$17M$16M$16M$14M$16M
Total Liabilities & Equity$25M$21M$23M$22M$24M
— Key Metrics —
Total Debt$2M$1M$1M$1M$566K
Net Debt-$2M-$795K-$1M-$883K-$3M
Total Investments$1M$628K$512K$1M$521K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms